Sarcomeric tropomyosin expression during human iPSC differentiation into cardiomyocytes

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• Tropomyosin (TPM) proteins are crucial for sarcomere structure and function in muscle cells.
• Alternative splicing and promoter usage of four TPM genes (TPM1-4) generate diverse protein isoforms.
• Understanding TPM isoform dynamics during cardiac development is essential for regenerative medicine.

Purpose of the Study:

• To investigate the expression patterns of sarcomeric tropomyosin isoforms during human induced pluripotent stem cell (hiPSC) differentiation into cardiomyocytes.
• To quantify changes in TPM transcript and protein levels throughout the cardiac differentiation process.

Main Methods:

• hiPSCs were differentiated into cardiomyocytes over 20 days, with samples collected at Days 0, 5, 10, 15, and 20.
• Quantitative real-time PCR (qRT-PCR) was used to analyze TPM transcript expression.
• Two-dimensional Western blotting with a specific antibody, followed by mass spectrometry, identified TPM protein isoforms.

Main Results:

• Total TPM transcripts and proteins increased during differentiation.
• Specific TPM isoform expression varied, with TPM1α transcripts and proteins being most abundant by Day 20.
• Novel detection of lower molecular weight TPM3 isoforms during cardiac differentiation, specifically on Day 15.

Conclusions:

• Cardiac differentiation involves dynamic regulation of TPM isoform expression.
• TPM1α is the predominant sarcomeric TPM isoform in differentiated cardiomyocytes.
• This study provides the first evidence of TPM1μ non-muscle isoform protein expression during cardiac differentiation.